Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape

Department of Experimental Medicine, Sapienza University of Rome, Roma, Latium, Italy
Gastroenterology (Impact Factor: 16.72). 07/2005; 128(7):1796-804. DOI: 10.1053/j.gastro.2005.03.045
Source: PubMed


Normal and neoplastic cells release microvesicles, whose effects on the immune system still need to be elucidated. Because human colorectal cancer cells are hypothesized to escape immune recognition by expressing proapoptotic molecules, we investigated whether microvesicles bearing Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand and inducing apoptosis of activated T cells are secreted by colorectal cancer cells both in vitro and in affected patients.
Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand expression were analyzed in colorectal cancer cells and purified microvesicles by flow cytometry, Western blotting, and immunoelectron microscopy. Microvesicle tumor origin was assessed through simultaneous detection of lysosomal (CD63) and adenocarcinoma (carcinoembryonic antigen) markers. Proapoptotic activity of microvesicles was evaluated by annexin V/propidium iodide staining and caspase activation in T cells, including CD8+ T lymphocytes from colorectal cancer patients.
Colorectal cancer cells showed a granular pattern of tumor necrosis factor-related apoptosis-inducing ligand and Fas ligand expression, suggesting a secretory behavior. These proapoptotic molecules were detected on isolated microvesicles, together with class I HLA, CD63, and carcinoembryonic antigen. Microvesicles induced Fas ligand-mediated and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of activated CD8+ T cells generated from colorectal cancer patients. Microvesicles with comparable phenotypes and functions were found in plasma from patients with advanced disease, whereas vesicular structures expressing Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand were also detected in colorectal cancer specimens.
These data show that colorectal cancer induces T-cell apoptosis through the release of Fas ligand-bearing and tumor necrosis factor-related apoptosis-inducing ligand-bearing microvesicles both in vitro and in vivo. This mechanism of immune escape has potential implications as a prognostic factor and could be targeted for the development of new antitumor therapies in colorectal cancer patients.

Download full-text


Available from: Marisa Colone,
  • Source
    • "We can also detect cell-specific composition and abundance of proteins such as Survivin in exosomes that may be useful to reveal different cellular behaviors. Exosomes from various cancer cells express Fas ligand which induces T-cell apoptosis and abolishes the function of adaptive immune cells (Andreola et al., 2002; Huber et al., 2005). Alternatively, platelet-derived exosomes were shown to transfer integrins to breast and lung cancer cells (Janowska-Wieczorek et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The tumor microenvironment plays an integral part in the biology of cancer, participating in tumor initiation, progression, and response to therapy. Factors released by tumor cells themselves contribute in creating an environment mostly favorable but sometimes detrimental to the tumor. Survivin, one of the key members of the inhibitor of apoptosis (IAP) family of proteins, has been shown in the cytoplasm, mitochondria, nucleus, and most recently in the extracellular space, transported via small membrane bound vesicles called exosomes. Exosomes are secreted from hematopoietic, non-hematopoietic, tumor, and non-tumor cells, shuttling essential molecules such as proteins, RNAs, and microRNAs, all believed to be important for cell-cell and cell-extracellular communication. In this review, we discuss exosomal Survivin and its role in modifying the tumor microenvironment.
    Histology and histopathology 06/2015; 30(1):43-50. · 2.10 Impact Factor
    • "re on multiple levels with the immune system ( Chaput and Théry , 2011 ) . For instance , they are capable to interact directly with CD8 positive T cells and to induce apoptosis via the FAS ligand . This was shown for several tumour cell lines and for primary tumour - derived EVs obtained from patient plasma and ascites ( Andreola et al . , 2002 ; Huber et al . , 2005 ; Kim et al . , 2005 ; Wieck - owski et al . , 2009 ; Peng et al . , 2011 ) . Furthermore , tumour - derived EVs induce the proliferation of reg - ulatory T cells ( Szajnik et al . , 2010 ) and inhibit the proliferation of effector T cells dependent on inter - leukin 2 ( Clayton et al . , 2007 ) . Tumour - derived EVs suppress the funct"
    [Show abstract] [Hide abstract]
    ABSTRACT: The discovery of exosomes, which are small, 30-100 nm sized extracellular vesicles that are released by virtual all cells, has initiated a rapidly expanding and vibrant research field. Current investigations are mainly directed toward the role of exosomes in intercellular communication and their potential value as biomarkers for a broad set of diseases. By horizontal transfer of molecular information such as micro RNAs, messenger RNAs, or proteins, as well as by receptor-cell interactions, exosomes are capable to mediate the reprogramming of surrounding cells. Herein, we review how especially cancer cells take advantage of this mechanism to influence their microenvironment in favour of immune escape, therapy resistance, tumour growth, and metastasis. Moreover, we provide a comprehensive microarray analysis (n>1,970) to study the expression patterns of genes known to be intimately involved in exosome biogenesis across 26 different cancer entities and a normal tissue atlas. Consistent with the elevated production of exosomes observed in cancer patient plasma, we found a significant overexpression especially of RAB27A, CHMP4C, and SYTL4 in the corresponding cancer entities as compared to matched normal tissues. Finally, we discuss the immune-modulatory and anti-tumorigenic functions of exosomes as well as innovative approaches to specifically target the exosomal circuits in experimental cancer therapy. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Biology of the Cell 04/2015; 107(9). DOI:10.1111/boc.201400095 · 3.51 Impact Factor
  • Source
    • "However, NKG2D downregulation is not the sole mediator of exosomally-induced immune escape. In line with recent evidence of Fas-L-expressing tumor exosomes [7], [26], [42], [43], we have observed that secreted exosomes from human prostate 22Rv1 cells express Fas-L and induce apoptosis in activated Fas-expressing CD8+ T cells (data not shown). These findings emphasize tumor exosomes as pluripotent suppressors of the immune response. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Tumor-derived exosomes, which are nanometer-sized extracellular vesicles of endosomal origin, have emerged as promoters of tumor immune evasion but their role in prostate cancer (PC) progression is poorly understood. In this study, we investigated the ability of prostate tumor-derived exosomes to downregulate NKG2D expression on natural killer (NK) and CD8 + T cells. NKG2D is an activating cytotoxicity receptor whose aberrant loss in cancer plays an important role in immune suppression. Using flow cytometry, we found that exosomes produced by human PC cells express ligands for NKG2D on their surface. The NKG2D ligand-expressing prostate tumor-derived exosomes selectively induced downregulation of NKG2D on NK and CD8 + T cells in a dose-dependent manner, leading to impaired cytotoxic function in vitro. Consistent with these findings, patients with castration-resistant PC (CRPC) showed a significant decrease in surface NKG2D expression on circulating NK and CD8 + T cells compared to healthy individuals. Tumor-derived exosomes are likely involved in this NKG2D downregulation, since incubation of healthy lymphocytes with exosomes isolated from serum or plasma of CRPC patients triggered downregulation of NKG2D expression in effector lymphocytes. These data suggest prostate tumor-derived exosomes as down-regulators of the NKG2D-mediated cytotoxic response in PC patients, thus promoting immune suppression and tumor escape.
    PLoS ONE 10/2014; 9(9). DOI:10.1371/journal.pone.0108925 · 3.23 Impact Factor
Show more